Inspire Medical Systems (NYSE:INSP – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, profitability, analyst recommendations and dividends.
Risk and Volatility
Inspire Medical Systems has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500.
Earnings & Valuation
This table compares Inspire Medical Systems and Integra LifeSciences”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Inspire Medical Systems | $755.59 million | 7.45 | -$21.15 million | $1.07 | 175.49 |
| Integra LifeSciences | $1.56 billion | 1.07 | $67.74 million | ($0.09) | -242.22 |
Profitability
This table compares Inspire Medical Systems and Integra LifeSciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Inspire Medical Systems | 4.37% | 5.30% | 4.58% |
| Integra LifeSciences | -0.42% | 12.35% | 4.82% |
Analyst Ratings
This is a summary of recent ratings and target prices for Inspire Medical Systems and Integra LifeSciences, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Inspire Medical Systems | 0 | 3 | 9 | 0 | 2.75 |
| Integra LifeSciences | 3 | 4 | 1 | 0 | 1.75 |
Inspire Medical Systems presently has a consensus price target of $233.58, indicating a potential upside of 24.40%. Integra LifeSciences has a consensus price target of $23.00, indicating a potential upside of 5.50%. Given Inspire Medical Systems’ stronger consensus rating and higher possible upside, analysts plainly believe Inspire Medical Systems is more favorable than Integra LifeSciences.
Institutional & Insider Ownership
94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by company insiders. Comparatively, 3.1% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
Inspire Medical Systems beats Integra LifeSciences on 10 of the 14 factors compared between the two stocks.
About Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
About Integra LifeSciences
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
